USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Eur Urol. 2017 Nov;72(5):814-820. doi: 10.1016/j.eururo.2017.02.024. Epub 2017 Mar 18.
Retroperitoneal lymph node dissection (RPLND) is an important component of the management of testicular germ cell tumor (GCT) but carries significant surgical morbidity.
To describe our experience with a midline extraperitoneal (EP) approach to RPLND for seminomatous and nonseminomatous GCT.
DESIGN, SETTING, AND PARTICIPANTS: From 2010 to 2015, 122 consecutive patients underwent RPLND from a prospective database. Patients requiring aortic resection or retrocrural dissection or with intraperitoneal disease were excluded. The remaining 69 patients underwent midline EP-RPLND.
Open midline EP-RPLND was performed using a standardized technique.
Perioperative and long-term outcomes were analyzed. Complications were graded using the Clavien-Dindo classification. A descriptive analysis using SAS software was performed.
A total of 68 patients underwent midline EP-RPLND successfully (98.6%). The median age was 28 yr (range 17-55). On preoperative imaging the size of the retroperitoneal mass or lymphadenopathy was <2cm in 29 patients, 2-4.9cm in 15 patients, and >5cm in 24 patients, of which 19 were >10cm. The median estimated blood loss was 325ml (interquartile range [IQR] 200-612.5). The median number of lymph nodes resected was 36 (IQR 24.5-49); the median number of positive nodes was one (IQR 0-4). The median time for return of bowel function was 2 d (IQR 1-2) and hospital stay 3 d (IQR 3-4). There were no cases of ileus. Eleven patients had 12 (17.6%) 90-d complications. Of these, six (55%) were Clavien grade 1, five (45%) were grade 2, and one was grade 3b (1.5%). Antegrade ejaculation rates were 91.6% in the primary group and 96.8% in the post-chemotherapy group.
Midline EP-RPLND can be performed safely without compromising the completeness of the resection. This approach is associated with rapid return of bowel function, minimal rates of ileus, and short hospital stay.
A midline extraperitoneal approach for retroperitoneal lymph node dissection in testicular cancer is safe and effective and leads to faster return of bowel function and earlier discharge.
腹膜后淋巴结清扫术(RPLND)是睾丸生殖细胞肿瘤(GCT)治疗的重要组成部分,但具有显著的手术发病率。
描述我们在精原细胞瘤和非精原细胞瘤 GCT 中采用中线腹膜外(EP)入路进行 RPLND 的经验。
设计、地点和参与者:从 2010 年到 2015 年,122 例连续患者从一个前瞻性数据库中接受了 RPLND。排除需要主动脉切除或 retrocrural 解剖或有腹腔内疾病的患者。其余 69 例患者接受中线 EP-RPLND。
采用标准化技术进行开放中线 EP-RPLND。
术后结果和长期结果进行分析。并发症采用 Clavien-Dindo 分类进行分级。采用 SAS 软件进行描述性分析。
共有 68 例患者成功接受中线 EP-RPLND(98.6%)。中位年龄为 28 岁(范围 17-55 岁)。术前影像学检查显示,腹膜后肿块或淋巴结病的大小<2cm 29 例,2-4.9cm 15 例,>5cm 24 例,其中 19 例>10cm。中位估计失血量为 325ml(四分位距[IQR]200-612.5)。中位切除的淋巴结数为 36 个(IQR 24.5-49);中位阳性淋巴结数为 1 个(IQR 0-4)。肠功能恢复的中位时间为 2d(IQR 1-2),住院时间为 3d(IQR 3-4)。无肠梗阻发生。11 例患者出现 12 例(17.6%)90 天并发症。其中,6 例(55%)为 Clavien 1 级,5 例(45%)为 2 级,1 例为 3b 级(1.5%)。原发组顺行射精率为 91.6%,化疗后组为 96.8%。
中线 EP-RPLND 可安全进行,不影响切除的完整性。这种方法与更快的肠功能恢复、极低的肠梗阻发生率和较短的住院时间相关。
睾丸癌腹膜后淋巴结清扫的中线腹膜外入路安全有效,可更快恢复肠道功能并提前出院。